Skip to main content
Premium Trial:

Request an Annual Quote

Ameritox Licenses Ridge Diagnostics' Depression Biomarker Test

NEW YORK (GenomeWeb News) – San Diego-based Ridge Diagnostics today said that it has licensed exclusive rights to Ameritox to its MDDScore, a multiplex biomarker test for major depressive disorder.

Ameritox, a Baltimore-based specialized lab testing firm, also will make an undisclosed equity investment in Ridge and has committed to a next-stage clinical development program.

The MDDScore test measures 10 biomarkers associated with factors such as inflammation, development and maintenance of neurons, and interaction between brain structures involved in stress response and other biological functions, said Ridge. The test is designed to help physicians determine whether a patient has major depression and may help the physician in matching the proper treatment to the patient.

"Ameritox's investment in Ridge will likely accelerate the MDDScore test development and advance access to millions of patients already under the care of primary care and pain management physicians," Ridge Diagnostics CEO Lonna Williams said in a statement.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.